145 related articles for article (PubMed ID: 16200074)
1. Detection of malignancy in cytology specimens using spectral-spatial analysis.
Angeletti C; Harvey NR; Khomitch V; Fischer AH; Levenson RM; Rimm DL
Lab Invest; 2005 Dec; 85(12):1555-64. PubMed ID: 16200074
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic classification of urothelial cells in urine cytology specimens using exclusively spectral information.
Jaganath R; Angeletti C; Levenson R; Rimm DL
Cancer; 2004 Jun; 102(3):186-91. PubMed ID: 15211478
[TBL] [Abstract][Full Text] [Related]
3. Performance of an artificial intelligence algorithm for reporting urine cytopathology.
Sanghvi AB; Allen EZ; Callenberg KM; Pantanowitz L
Cancer Cytopathol; 2019 Oct; 127(10):658-666. PubMed ID: 31412169
[TBL] [Abstract][Full Text] [Related]
4. Quantitative phase imaging to improve the diagnostic accuracy of urine cytology.
Pham HV; Pantanowitz L; Liu Y
Cancer Cytopathol; 2016 Sep; 124(9):641-50. PubMed ID: 27177072
[TBL] [Abstract][Full Text] [Related]
5. Cytologic diagnosis of low-grade papillary urothelial neoplasms (low malignant potential and low-grade carcinoma) in the context of the 1998 WHO/ISUP classification.
Whisnant RE; Bastacky SI; Ohori NP
Diagn Cytopathol; 2003 Apr; 28(4):186-90. PubMed ID: 12672093
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
7. Reclassification of urinary cytology regarding The Paris System for Reporting Urinary Cytology with cytohistological correlation demonstrates high sensitivity for high-grade urothelial carcinoma.
Anbardar MH; Monjazeb R
Diagn Cytopathol; 2020 May; 48(5):446-452. PubMed ID: 31976626
[TBL] [Abstract][Full Text] [Related]
8. A Review of Urine Ancillary Tests in the Era of the Paris System.
Allison DB; VandenBussche CJ
Acta Cytol; 2020; 64(1-2):182-192. PubMed ID: 31060038
[TBL] [Abstract][Full Text] [Related]
9. Utility of the Paris System in Reporting Urine Cytology.
Malviya K; Fernandes G; Naik L; Kothari K; Agnihotri M
Acta Cytol; 2017; 61(2):145-152. PubMed ID: 28380477
[TBL] [Abstract][Full Text] [Related]
10. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study.
VandenBussche CJ; Sathiyamoorthy S; Owens CL; Burroughs FH; Rosenthal DL; Guan H
Cancer Cytopathol; 2013 Jan; 121(1):21-8. PubMed ID: 23192913
[TBL] [Abstract][Full Text] [Related]
11. Current status of urinary cytology in the evaluation of bladder neoplasms.
Murphy WM
Hum Pathol; 1990 Sep; 21(9):886-96. PubMed ID: 2203672
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an artificial intelligence algorithm for assisting the Paris System in reporting urinary cytology: A pilot study.
Ou YC; Tsao TY; Chang MC; Lin YS; Yang WL; Hang JF; Li CB; Lee CM; Yeh CH; Liu TJ
Cancer Cytopathol; 2022 Nov; 130(11):872-880. PubMed ID: 35727052
[TBL] [Abstract][Full Text] [Related]
13. [The value of urinary cytology in the diagnosis of high grade urothelial tumors].
Niedworok C; Rembrink V; Hakenberg OW; Börgermann C; Rossi R; Schneider T; Becker M; Szarvas T; von Ostau C; Swoboda A; Rübben H; vom Dorp F
Urologe A; 2009 Sep; 48(9):1018, 1020-2, 1024. PubMed ID: 19697005
[TBL] [Abstract][Full Text] [Related]
14. Use of mailed urine specimens in diagnosing urothelial carcinoma by cytology and DNA image analysis.
Liu J; Katz R; Shin HJ; Johnston DA; Zhang HZ; Caraway NP
Acta Cytol; 2005; 49(2):157-62. PubMed ID: 15839620
[TBL] [Abstract][Full Text] [Related]
15. A Novel Urine-Based Assay for Bladder Cancer Diagnosis: Multi-Institutional Validation Study.
Davis N; Shtabsky A; Lew S; Rona R; Leibovitch I; Nativ O; Cohen M; Mor Y; Lindner U; Glickman Y; Matzkin H; Tsivian A; Gofrit O; Yossepovitch O
Eur Urol Focus; 2018 Apr; 4(3):388-394. PubMed ID: 28753799
[TBL] [Abstract][Full Text] [Related]
16. Hypochromatic large urothelial cells in urine cytology are indicative of high grade urothelial carcinoma.
Pierconti F; Martini M; Straccia P; Fiorentino V; Musarra T; Larocca LM; Lopez-Beltran A
APMIS; 2018 Sep; 126(9):705-709. PubMed ID: 30160022
[TBL] [Abstract][Full Text] [Related]
17. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of atypical urine cytology progression to malignancy.
Muus Ubago J; Mehta V; Wojcik EM; Barkan GA
Cancer Cytopathol; 2013 Jul; 121(7):387-91. PubMed ID: 23536358
[TBL] [Abstract][Full Text] [Related]
19. The cytomorphological features of low-grade urothelial neoplasms vary by specimen type.
Zhang ML; Rosenthal DL; VandenBussche CJ
Cancer Cytopathol; 2016 Aug; 124(8):552-64. PubMed ID: 27019161
[TBL] [Abstract][Full Text] [Related]
20. Adequacy criteria for voided urine cytology using cytospin preparations.
Renshaw AA; Gould EW
Cancer Cytopathol; 2019 Feb; 127(2):116-119. PubMed ID: 30561909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
